STOCKS TELEGRAPH

Tag: ONTX

  • Oncova Therapeutics Inc. (ONTX) plunged in the premarket; here’s why

    Oncova Therapeutics Inc. (ONTX) plunged in the premarket; here’s why

    In the premarket, ONTX stock plunged by -3.42% ($0.77) at the time of writing. ONTX stock closed Thursday’s session at $0.80 gaining 21.63%. The stock volume traded is 17.96M shares and the average volume of the past 3 months is 43.60M.

    ONTX stock’s operations and investigational candidates

    Oncova Therapeutics Inc. is a biopharmaceutical company that specifically focuses on the design and development of novel treatments for the treatment of cancers. The company’s investigational candidate product is rigosertib which is currently being studied in the dose-escalation and Phase I expansion for focusing patients with KRAS+ lung adenocarcinoma along with the use of nivolumab. Risosertib is also being focused for the testing in COVID-19.

    The company also has the candidate ON123300 which is a proprietary multi-kinase inhibitor and on 1st April 2021, announced starting ON123300’s dose-escalation and expansion phase I’s second cohort trial in China for HR+ HER2- metastatic breast cancer and refractory cancers. Three patients have been enrolled by ONTX’s corporate partner HanX Biopharmaceuticals for the second cohort.  It is planning to initiate the same trial in USA in the second quarter of 2021.

    First patient has been dosed in the Phase 2 study of Rigosertib

    The company announced on 22nd April 2021, that its investigator-initiated Phase 2 study of Rigosertib has started the first-dosage in first of its patients for targeting recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma.

    The study involves 12 patients who will receive Rigosertib in either oral or intravenous form depending upon if the patient has esophageal stricture (recommend intravenous administration) or skin desquamation (recommend oral administration). The period of testing and dosing will be a four-week cycle leading up to 13 cycles. The dosage quantity was oral 1120 mg in a day, halved by morning and afternoon and for intravenous it was a 72-hour infusion with each infusion for 24 hour period consisting of 1800 mg of Rigosertib.

    Full Year Financials review

    ONTX stock released its Full Year 2020 financial results report on 12th March. While the fourth quarter of 2020 in the report did highlight positive news related to clinical and trial approvals, the financials of the full year did perform weakly. The financial results of full-year 2020 may have weakened in comparison to 2019’s result but it is important to keep in mind that many biotech penny stocks had plunged its financial performance in 2020 due to the pandemic, so the financial performance scale is relative for the year 2020 in these stocks.

    Furthermore, the company generated Cash and Cash Equivalents of $19.0 million for the Full-year ending December 31, 2020, and expects its current Cash and Cash equivalents to be sufficient for funding trials and business operations for more than 18 months.

    So what is the outlook for ONTX stock?

    With penny stocks such as ONTX stock, no matter what fluctuations and volatility it reacts to, the fundamentals of the company are relatively a solid point of analysis to look at before investing in it. A factor to keep in mind while looking to buy ONTX stock is the importance of the stock movement trend far outweighs the outlook of ONTX.

    Another fundamental thing to look at for the ONTX is its balance sheet. If the current status of the balance sheet is healthy then it determines that ONTX can carry out its all financial and non-financial obligations while adhering to the investor’s interest.

  • What’s going on with Onconova Therapeutics Inc. (ONTX) stock?

    Onconova Therapeutics Inc. (ONTX) is going up in the pre-market on March 18, 2021, as of this writing. The stock went up 14.95% yesterday as well. Still, there is no latest development to support their gains. Let us have a look at the recent past developments.

    Recent ONTX news

    On Friday, March 12, 2021, ONTX announced its financial results for the twelve months ended December 31, 2020.

    Full-year Financial highlights

    • ONTX spent $16.9 million in Research and development expenses, compared to $15.5 million for 2019.
    • General and administrative expenses were $8.3 million for 2020, consistent with 2019.
    • Onconova Therapeutics Inc. suffered a net loss of $25.2 million, or $0.14 per share, compared with a loss of $21.5 million, or $1.49 per share for 2019
    • As of December 31, 2020 ONTX, had Cash and cash equivalents were $19.0 million, compared with $22.7 million in the prior year.

    Participation in Three Investment Conferences

    Onconova Therapeutics has participated virtually in three investors conference in March 2021. The company participated in

    • The H.C. Wainwright Global Life Sciences Virtual Conference with one-on-one meetings held onMarch 9-10, 2021
    • The Virtual 33rd Annual Roth Conference with one-on-one meetings held on March 15-17, 2021
    • The Maxim Group Emerging Growth Virtual Conference being held March 17-18, 2021 with one-on-one meetings scheduled after the event

    About the company

    Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing products for patients with cancer. The company was formed in 1998. Its headquarter is in Pennsylvania, the United States and it startedtrading on the NASDAQ stock exchange under the ticker symbol ONTX in July 2013. Onconova’s proprietary multi-kinase inhibitor ON 123300 is planned to begin a dose-escalation and expansion Phase 1 trial in the U.S. in the first half of 2021, and a dose-escalation and expansion Phase 1 trial is currently underway in China.

    Steven M. Fruchtman, M.D. is the president and CEO of the company. Dr. Fruchtman joined Onconova in January 2015 as Chief Medical Officer. He has extensive experience in large and small biopharmaceutical companies and has led successful clinical development programs while serving in senior positions at many Pharmaceutical companies. He is an author of more than 170 lectures, presentations, books, chapters, and abstracts and serves as an external reviewer for multiple medical journals. He received his medical degree from New York Medical College with the distinction of membership in the Alpha Omega Alpha honorary medical fraternity.

  • Here’s what to look out for if you want to invest in Onconova Thereapeutics Inc. (ONTX) stock

    Here’s what to look out for if you want to invest in Onconova Thereapeutics Inc. (ONTX) stock

    The Onconova Thereapeutics Inc. (NASDAQ: ONTX) stock fell by -4.46% to the current price of $1.07. The ONTX stock previously closed at $1.12.

    ONTX Full Year 2020 report has mixed news

    There seems to be no exact press news with the last 24-hours that could explain the plunge in the ONTX stock movement. However, ONTX did release its Full Year 2020 financial results report on March 12. While the fourth quarter of 2020 in the report did highlight positive news related to clinical and trial approvals, the financials of the entire year did have some shaky prospects.

    Let’s look at the good news first. FDA approved the clearance of the ON 123300to begin its 1st phase trial. ON 123300 also received approval by IRB at one US trial site. Phase 1 of the ON 123300 solid tumor study is ongoing and enrolling patients. An investigator-initiated study with oral rigosertib in advanced KRAS mutated non-small cell lung cancer is also persistent.

    The financial results have questionable prospects

    However, when it comes to the financial results of the report, we see that the cash and cash equivalents as of December 31, 2020, were $19.0 million, which is $3.7 million less than December 31, 2019financials. Net loss for 2020 was $25.2 million which is greater than the $21.5 million loss in 2019. General and administrative expenses were $8.3 million for both years, which shows consistency as lower personnel stock compensation due to personnel reductions in 2019 were offset by corporate legal and stockholder meeting expenses.

    Research and development expenses were $16.9 million for 2020 compared with $15.5 million for 2019, while ONTX stock raised net proceeds of $35.2 million from two equity offerings with institutional investors.

    What you need to understand about ONTX

    Investors like to identify the Biotech stock ONTX as an attractive stock to keep an eye on. However, with such penny stocks, no matter what fluctuations and volatility it reacts to, the fundamentals of the company are relatively a solid point of analysis to look at before investing in it. The first fundamental thing to look at for the ONTX is its balance sheet. Suppose the current status of the balance sheet is healthy. In that case, it determines that ONTX can carry out all its financial and non-financial obligations while adhering to the investor’s interest.

    Another factor to keep in mind while deciding to buy ONTX stock is that the importance of the stock movement trend far outweighs the outlook of ONTX.

  • Early Morning Vibes: 4 Stocks We Like for Monday…

    Early Morning Vibes: 4 Stocks We Like for Monday…

    The American stock markets could not be fired ahead last week. The results were limited and as you can see on the graph below, the S&P 500 continued to stabilize at around 3900 points. On Friday, the broad-based index closed 0.19% lower at 3,906 points and the Nasdaq was up 0.07% the day at 13,874 points.

    Investors are clearly waiting for new impulses but are also awaiting developments in the bond markets. Inflation expectations are increasing rapidly, and interest rates are also rising. The market now seems somewhat concerned that central banks will have to reduce the support measures or even raise interest rates sooner than expected. Finance minister Janet Yellen, however, said on Friday that governments must come up with a large package of support to revive economic growth.

    Currently, futures in New York are up to 1 percent lower. The European stock markets are also following the red figures. The decline again appears to be a direct result of rising interest rates. Furthermore, China yesterday asked the US to lift tariffs and other trade sanctions. China’s Foreign Minister continues to push for better US-China partnerships on technological progress. It remains to be seen how Joe Biden will react to the proposal, after his predecessor Trump just imposed strict measures.

    Meanwhile, Gold prices have been under pressure for several weeks, but on Friday even the support seemed to break at $ 1,764 (bottom November 30). However, the fear of rising interest rates is positive for gold and the price recovered. But watch out; higher interest rates are not good for gold, but the turmoil in the markets is. This morning, the gold price is at least 0.51% higher at $ 1792, but the danger is not over yet. The gold price is in a downward trend channel. A break above the last market stop at around $ 1,860 is necessary for technical improvement.

    Today Top Movers‎‎

    ‎Xcel Brands Inc. (XELB), an apparel manufacturing company, rose about 44.91% at ‎‎$2.92 in pre-market trading Monday.‎‎‎ ‎

    ‎China SXT Pharmaceuticals Inc. (SXTC) stock soared 280.89% to $2.99 in the pre-market trading. The company recently declared that a 1 for 4 reverse split of its ordinary shares was approved by the Company’s board of directors on January 23, 2021 and is expected to become effective on February 19, 2021.‎‎ ‎

    ‎ReTo Eco-Solutions Inc. (NASDAQ: RETO) shares are trading up 116.1% at $2.55 at the time of writing. ‎‎ ‎

    ‎RealNetworks Inc. (RNWK) grew over 12.68% at $4.0 in pre-market trading today.‎

    Top Upgrades & Downgrades

    KeyBanc turned bullish on AvalonBay Communities Inc. (AVB), upgrading the stock to “Overweight” and assigning a $200.0 price target, representing a potential downside of 12.25% from Friday’s close. 

    Marathon Petroleum Corporation (MPC) has won the favor of JPMorgan’s equity research team. The firm upgraded the shares from Neutral to Overweight and moved their price target to $67. 

    JetBlue Airways Corporation (JBLU) received an upgrade from analysts at Deutsche Bank, who also set their one-year price target on the stock to $21. They changed their rating on JBLU to Buy from Hold in a recently issued research note.

    Earlier Monday KeyBanc reduced its rating on Camden Property Trust (CPT) stock to Sector Weight from Overweight. 

    Kansas City Capital analysts reduced their investment ratings, saying in research reports covered by the media that it’s rating for Valmont Industries Inc. (VMI) has been changed to Perform from Outperform. 

    Analysts at RBC Capital downgraded AngloGold Ashanti Limited (AU)’s stock to Sector Perform from Outperform Monday.

    Latest Insider Activity

    Palantir Technologies Inc. (PLTR) Director THIEL PETER announced the sale of shares taking place on Feb 18 at $25.23 for some 20,003,915 shares. The total came to more than $504.78 million. 

    Tesla Inc. (TSLA) Chief Financial Officer Kirkhorn Zachary sold on Feb 17 a total of 55,007 shares at $778.17 on average. The insider’s sale generated proceeds of almost $0.97 million. 

    Onconova Therapeutics Inc. (ONTX) SVP Corp Dev & Gen Counsel OLER ABRAHAM N. declared the purchase of shares taking place on Feb 16 at $1.00 for some 12,000 shares. The transaction amount was around $12000.0. 

    JMP Group LLC (JMP) Possible Member of 10% Group WEDBUSH SECURITIES INC bought on Feb 11 a total of 2,019,000 shares at $4.74 on average. The purchase cost the insider an estimated $920.

    Important Earnings

    Top US earnings releases scheduled for today include Marathon Oil Corporation (NYSE: MRO). It will announce its Dec 2020 financial results. The company is expected to report earnings of -$0.2 per share from revenues of $838.05M in the three-month period. 

    Analysts expect Occidental Petroleum Corporation (NYSE: OXY) to report a net income (adjusted) of -$0.59 per share when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended Dec 2020 is predicted to come in at $4.37B. 

    Invesco Mortgage Capital Inc. (IVR), due to announce earnings after the market closes today, is expected to report earnings of $0.06 per share from revenues of $29.16M recently concluded three-month period.

  • Onconova Therapeutics (ONTX): The Penny Stock Moving towards Per Share, What’s Happening?

    Onconova Therapeutics (ONTX): The Penny Stock Moving towards $2 Per Share, What’s Happening?

    ONTX shares have skyrocketed over 250% so far this year. What’s coming up next?

    Shares of Onconova Therapeutics (ONTX) have been on a skywalk. The biopharmaceutical has recorded a jump of over 250%+ in its stock since the start of 2021. There have been some bulls that are pushing the penny stock as it moves towards the $2 per share.

    Let’s see what’s all this bullish sentiment is about and what’s happening around?

    What’s Happening?

    The company recently raised $28.75 million through a stock offering, which has been the main reason behind the bullish sentiment, lately. The biotech sold 28.75 million shares at a per-share price of $1.

    The company expects to use the gross proceeds from the stock sale to strengthen its balance sheet and provide more cash for its cancer-treatment development programs. 

    Early this year, the company signed a definitive purchase agreement with accredited institutional investors to sell 19.55 million of its common stock in a registered direct offering. The company sold its shares at a purchase price of $0.445 per share. The overall proceeds from the offering are $8.7 million.

    The company is moving closer to its objective one by one. All this fundraising has been to keep the business running smoothly and support its cancer treatment development program. In that premise, the company obtained the FDA approval to begin Phase 1 study of its proprietary, differentiated, first-in-class multi-kinase inhibitor, ON 123300.

    The company will study the efficacy of ON 123300 under its Investigational New Drug application (IND). The trial will enroll patients with relapsed/refractory advanced cancer, also including patients with HR+ HER2- metastatic breast cancer.

    This is a great achievement for Onconova Therapeutics to set its first step on the right track to get things going. The CEO of the company, Steven M. Fruchtman said that they are advancing the process to secure Institutional Review Board approval and believe that they will enroll the first patient during the first half of 2021.

    Conclusion

    The 52-week high for Onconova Therapeutics (ONTX) has been $1.80 per share. As we write this, ONTX shares trade around $1.63, up by 8.63%. Considering the bullish sentiment, things have been good for ONTX since the FDA approval for ON 123300. But, the real value of just lies below $1. For now, it doesn’t seem to cross $2 but if the company gets a breakthrough in the initial phase of its cancer study, ONTX can rally past $2.

  • Early Morning Vibes: Don’t Miss On These 4 Growth Stocks

    Early Morning Vibes: Don’t Miss On These 4 Growth Stocks

    On February 17, American stock exchanges closed in different directions. The S&P 500 index dropped by a purely symbolic 0.03%, to 3931 points, the NASDAQ lost 0.58%, and the Dow Jones added 0.29%. Retail sales rose sharply in January thanks to direct payments to the public, which supported the bullish sentiment. The market saw a capital flow from growth stocks to value stocks, which made the IT sector an outsider, losing 1.03%. The energy sector remained among the leaders and grew by 1.45% amid rising oil prices.

    Company news

    QuantumScape (QS: + 31.4%) announced a breakthrough in the development of next generation solid state batteries.

    Popular website builder Wix.com’s quarterly results (WIX: + 8.1%) exceeded expectations, as did the company’s forecasts for 2021.

    Shopify’s (SHOP: -3.3%) revenue and operating numbers were above consensus, but the stock is up more than 25% YTD, so investors have taken profits.

    Today, global stock exchanges are showing mostly negative dynamics. The published minutes of the FRS meeting, held on January 26-27, fully coincided with the expectations of investors. The meeting participants did not discuss the reduction of the asset purchase program, since macroeconomic indicators do not allow even considering such a possibility. The factor of ultra-soft monetary policy has been in the field of view of investors for a long time, so the degree of its influence is gradually decreasing.

    Note that positive data on retail sales in January (+ 5.3% mom) confirmed the effectiveness of fiscal stimulation by direct payments to the population. The stimulus package currently under discussion includes direct payments of $ 1,400, more than double the previous subsidy. In this regard, a similar increase in consumer spending can be expected in April and May.

    In the short term, a correction in the S&P 500 index is not ruled out, since a sharp rise in bond yields and the prospects for an early opening of the economy may lead to some capital outflow from the US tech sector. Cyclical sectors can look stronger than the market.

    The data on the issued building permits for January will be published today. A slight decrease is expected compared to the previous month, when the highest level in more than 10 years was recorded (forecast: 1.678 million, previous value: 1.704 million). The real estate market remains in excellent shape, so a slight slowdown in construction growth will only protect it from overheating.

    The Freedom Finance Sentiment Index remains at 78 out of 100. The indicator reflects the hope of market participants for a recovery in the global economy in 2021. Concerns about the negative impact of the coronavirus pandemic are gradually diminishing thanks to the prospects for mass vaccinations.

    Technically, the S&P 500 is still in an uptrend. The upper limit of this trend still limits the growth potential of the broad market index. On the eve of the “bulls” showed weakness, which, however, turned out to be short-lived. In the short term, a correction or consolidation is likely, as the RSI indicator is forming a bearish divergence near the overbought zone.

    Today Top Movers

    Tilray Inc (TLRY) stock ascended 8.19% at $34.09 in the pre-market trading today after the company declared financial results for the full fiscal year and fourth quarter ended December 31, 2020.

    Avinger Inc (AVGR) gained over 58.58% at $2.68 in pre-market ‎trading on Thursday.‎‎ Avinger, Inc. to be issued US Patent No. 10,932,670 by the US Patent and Trademark Office on 3/2, titled: OPTICAL PRESSURE SENSOR ASSEMBLY.

    Onconova Therapeutics Inc (ONTX) grew over 15.23% at $1.74 in pre-market trading ‎today following the closing of a $28.75 million public offering of common stock.

    Luokung Technology Corp (LKCO) stock moved up 14.02 percent to $2.52 in the pre-market ‎trading. The firm recently declared a $100 million registered direct offering priced at the market under Nasdaq Rules.‎

    Top Upgrades & Downgrades

    Berenberg turned bullish on STMicroelectronics N.V. (STM), upgrading the stock to “Hold”. 

    Mohawk Industries Inc. (MHK) has won the favor of Credit Suisse’s equity research team. The firm upgraded the shares from Underperform to Neutral and moved their price target to $180. 

    Wells Fargo & Company (WFC) received an upgrade from analysts at JPMorgan, who also set their one-year price target on the stock to $37. They changed their rating on WFC to Neutral from Underweight in a recently issued research note. 

    Earlier Thursday Kepler Cheuvreux reduced its rating on TechnipFMC plc (FTI) stock to Hold from Buy and assigned the price target to 8.21. 

    Credit Suisse analysts reduced their investment ratings, saying in research reports covered by the media that it’s rating for Noble Midstream Partners LP (NBLX) has been changed to Neutral from Outperform and the new price target is set at $13.5. 

    Analysts at Baird downgraded Kratos Defense & Security Solutions Inc. (KTOS)’s stock to Neutral from Outperform Thursday.

    Latest Insider Activity

    Freeport-McMoRan Inc. (FCX) VP Controller & Financial Rptg WHITMIRE C DONALD JR announced the sale of shares taking place on Feb 12 at $30.84 for some 48,240 shares. The total came to more than $1.49 million. 

    Marvell Technology Group Ltd. (MRVL) CEO and President MURPHY MATTHEW J sold on Feb 16 a total of 282,328 shares at $53.20 on average. The insider’s sale generated proceeds of almost $0.4 million. 

    New York Community Bancorp, Inc. (NYCB) Director Rosenfeld Ronald A. declared the purchase of shares taking place on Feb 09 at $10.63 for some 5,000 shares. The transaction amount was around $53,169. 

    CVS Health Corporation (CVS) Director LUDWIG EDWARD J bought on Feb 17 a total 14,334 shares at $72.00 on average. The purchase cost the insider an estimated $216,000.

    Important Earnings

    Top US earnings releases scheduled for today include Barrick Gold Corporation (NYSE: GOLD). It will announce its Dec 2020 financial results. The company is expected to report earnings of $0.31 per share from revenues of $3.27B in the three-month period. 

    Analysts expect Walmart Inc. (NYSE: WMT) to report a net income (adjusted) of $1.51 per share when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended Jan 2021 is predicted to come in at $148.47B. 

    Host Hotels & Resorts Inc. (HST), due to announce earnings after the market closes today, is expected to report earnings of -$0.42 per share from revenues of $243.28M recently concluded three-month period.

  • Early Morning Vibes: Top 4 Stocks To Buy Right Now

    Early Morning Vibes: Top 4 Stocks To Buy Right Now

    Futures for major US stock indices rose on Thursday in anticipation of labor market statistics and a new portion of corporate reporting, according to trading data.

    Futures on the Dow Jones Industrial Average (DJIA) grew by 0.1%, to 30.660 points, on the NASDAQ high-tech index – by 0.41%, to 13449 points, on the broad market S&P 500 index – by 0.16%, up to 3829.88 points.

    Investors are watching for signs that the US economic recovery will continue, despite the large number of cases of infection with coronavirus and new strains of it, against which existing vaccinations may be less effective, which is fraught with new restrictive measures.

    In this light, the market is interested in the statistics of the initial jobless claims, which will be published later on Thursday. Analysts expect a decrease in this number by 17 thousand last week compared to the previous one, to 830 thousand applications.

    In addition, traders are waiting for a new portion of corporate reporting in the United States. For example, investment company Carlyle Group, pharmaceutical Bristol-Myers Squibb and tobacco Philip Morris International should disclose their financials for the past quarter before the opening of trading, and the automaker Ford Motor and Snap, which owns the social networking app Snapchat, are planning to publish a profit report and losses after their closure.

    Today Top Movers

    Bilibili Inc (BILI) share price jumped 11.14% to $150.25 during the early morning ‎trading session on ‎Thursday.‎ As of Q3 2020, Bilibili reported that its total number of monthly active users increased 54% year-over-year to 197.2 million. And the total paying users increased 89% to 15 million.‎

    Cassava Sciences Inc (SAVA) gained over 42.00% at $124.89 in pre-market ‎trading on Thursday.‎ The firm recently declared results of an interim analysis from an open-label study of simufilam, its lead drug candidate for the treatment of Alzheimer’s disease. ‎

    Onconova Therapeutics Inc (ONTX) grew over 6.70% at $0.90 in pre-market trading ‎today. Recently ONTX being granted a European patent for “The Treatment Of Hematological Cancer Refractory To An Anti-Cancer Agent.” 

    DraftKings Inc (DKNG) stock moved up 1.01 percent to $60.72 in the pre-market ‎trading.‎

    Top Upgrades & Downgrades

    Roth Capital turned bullish on Ocugen Inc. (OCGN), upgrading the stock to “Buy” and assigning a $1.0 price target, representing a potential upside of 60.14% from Wednesday’s close. 

    STERIS plc (STE) has won the favor of KeyBanc’s equity research team. The firm upgraded the shares from Sector Weight to Overweight and moved their price target to $224.0, suggesting a 22.45% additional upside for the stock. 

    FireEye Inc. (FEYE) received an upgrade from analysts at BofA, who also set their one-year price target on the stock to $27. They changed their rating on FEYE to Buy from Neutral in a recently issued research note. 

    Earlier Thursday HC Wainwright & Co. reduced its rating on GW Pharmaceuticals plc (GWPH) stock to Neutral from Buy and assigned the price target to $220.0. With shares trading at around $211.37, the Wall Street firm thinks GW Pharmaceuticals plc’s stock could add than 4.08%. 

    KeyBanc analysts reduced their investment ratings, saying in research reports covered by the media that it’s rating for Murphy Oil Corporation (MUR) has been changed to Sector Weight from Overweight. 

    Analysts at Oddo BHF downgraded GlaxoSmithKline plc (GSK)’s stock to Neutral from Buy Thursday.

    Latest Insider Activity

    Apple Inc. (AAPL) Director LEVINSON ARTHUR D announced the sale of shares taking place on Feb 02 at $135.60 for some 3,416 shares. The total came to more than $0.46 million. 

    Koss Corporation (KOSS) VP – Marketing & Product Koss Michael J Jr sold on Feb 02 a total 46,000 shares at $25.98 on average. The insider’s sale generated proceeds of almost $0.36 million. 

    MannKind Corporation (MNKD) Chief Executive Officer Castagna Michael declared the purchase of shares taking place on Jan 31 at $1.33 for some 5,000 shares. The transaction amount was around $6650. 

    Texas Instruments Incorporated (TXN) Director Craighead Martin S bought on Jan 28 a total 21,388 shares at $166.91 on average. The purchase cost the insider an estimated $997,294.

    Important Earnings

    Top US earnings releases scheduled for today include Nokia Corporation (NYSE: NOK). It will announce its Dec 2020 financial results. The company is expected to report earnings of $0.13 per share from revenues of $7.43B in the three-month period. 

    Analysts expect Ford Motor Company (NYSE: F) to report a net income (adjusted) of -$0.07 per share when the bank releases its quarterly results shortly. Revenue for the fiscal quarter ended Dec 2020 is predicted to come in at $33.89B. 

    Snap Inc. (SNAP), due to announce earnings after the market closes today, is expected to report earnings of $0.07 per share from revenues of $857.39M recently concluded three-month period.

  • 26 stocks trending in pre-market

    ‎Bionano Genomics Inc. (BNGO) stock soared 13.81% to $2.39 in the pre-‎market ‎trading following an announcement from the firm that Nasdaq has granted the Company an ‎additional ‎‎180-day compliance period, or until June 28, 2021. The most recent rating by Ladenburg ‎Thalmann, on ‎September 24, 2020, is a Buy. ‎

    Before the trading started on December 31, 2020, fuboTV Inc. (FUBO) is down -‎‎‎2.43% to reach $32.5. It has been trading in a 52-week range of $5.00 to $62.29.‎

    ‎Guardion Health Sciences Inc. (NASDAQ: GHSI) shares are trading down -10.77% ‎at ‎‎$0.5247 at the time of writing. The firm lately revealed the appointment of Bret Scholtes as ‎its ‎President and Chief Executive Officer, and as a member of the Board of Directors. Company’s 52-‎week ‎ranged between $0.17 to $0.74.‎

    ‎Nxt-ID Inc. (NXTD) stock soared 7.1% to $1.81 in the pre-market trading. ‎The ‎most ‎recent rating by Maxim Group, on November 20, 2017, is a Buy.‎

    ‎Castor Maritime Inc. (CTRM) grew over 41.75% at $0.33 in pre-market trading ‎today ‎after receiving 180-day extension from Nasdaq to meet Nasdaq minimum bid price rule. ‎

    ‎Net Element Inc. (NASDAQ: NETE) shares are trading down -5.21% at $15.45 at ‎the ‎time of writing. Company’s 52-week ranged between $1.47 to $20.08. ‎

    ‎Sundial Growers Inc. (SNDL) stock moved down -1.36 percent to $0.4784 in the pre-‎‎market trading following the declaration from the company that it has closed the acquisition of ‎a ‎special purpose vehicle. ‎

    ‎Professional Diversity Network Inc. (IPDN) gained over 14.96% at $3.15 in pre-‎‎market trading Thursday December 31, 2020 after the firm revealed its partnership with ‎Phala ‎Network.‎

    ‎Marathon Patent Group Inc. (MARA) is up more than 7.63% at $11.71 in pre-‎market ‎hours Thursday December 31, 2020. The company recently revealed that it has entered into a ‎contract ‎with Bitmain to purchase 70,000 Antminer S-19 ASIC miners. The stock had dropped over -‎‎7.48% to ‎‎$10.88 in the last trading session.‎

    ‎Riot Blockchain Inc. (RIOT), a Software – Application company, rose about ‎‎4.92% ‎at ‎‎$18.11 in pre-market trading Thursday.‎

    ‎Nano Dimension Ltd. (NNDM) stock moved up 2.09 percent to $9.75 in the pre-‎‎market trading after closing $250 million registered direct offering.‎

    ‎AIkido Pharma Inc. (AIKI) gained over 33.72% at $1.15 in pre-‎‎market ‎trading ‎Thursday December 31, 2020.‎

    ‎Color Star Technology Co. Ltd. (NASDAQ: CSCW) shares are trading down -4.38% ‎at ‎‎$0.8032 at the time of writing after declaring strategic partnership with two UAE ‎companies. ‎Company’s 52-week ranged between $0.31 to $2.06.‎

    ‎IMAC Holdings Inc. (IMAC) stock moved down -4.08 percent to $1.41 in the pre-‎‎market trading after reporting completion of first infusion of Stem Cells in clinical study for ‎the ‎treatment of Bradykinesia due to Parkinson’s disease.‎

    ‎Ampio Pharmaceuticals Inc. (AMPE) stock soared 12.84% to $1.67 in the pre-‎market ‎trading. The firm recently revealed that it has received guidance from the U.S Food & ‎Drug ‎Administration regarding the impact of COVID-19 on its Phase III clinical trial for osteoarthritis of ‎the ‎knee. The most recent rating by ROTH Capital, on December 19, 2019, is a Buy.‎

    ‎Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares are trading up 5.76% ‎at ‎‎$49.4 at the time of writing after the company announced that it would develop a therapeutic spray ‎as ‎a candidate to treat the hereditary lung and digestive-system disease cystic fibrosis. Company’s 52-‎‎week ranged between $8.51 to $129.71. Analysts have a consensus price target of $69. ‎

    Before the trading started on December 31, 2020, Baidu Inc. (BIDU) is up ‎‎3.53% ‎to ‎reach $227.38. It has been trading in a 52-week range of $82.00 to $202.79.‎

    ‎Greenpro Capital Corp. (GRNQ) is up more than 3.11% at $1.99 in pre-market ‎hours ‎Thursday December 31, 2020. The company lately revealed that it intends to set up a Bitcoin ‎‎($BTC) ‎Fund for investment. The stock had jumped over 3.76% to $1.93 in the last trading session.‎

    ‎Onconova Therapeutics Inc. (ONTX) is down more than -3.79% at $0.49 in pre-‎‎market hours Thursday December 31, 2020. The stock had jumped over 18.88% to $0.51 in the ‎last ‎trading session.‎

    ‎JinkoSolar Holding Co. Ltd. (JKS) grew over 2.28% at $65.55 in pre-market ‎trading ‎today. The firm recently revealed annual general meeting 2020 ‎results.‎

    ‎Tonix Pharmaceuticals Holding Corp. (TNXP) lost over -2.76% at $0.6632 in pre-‎‎market trading Thursday December 31, 2020.‎

    ‎Osmotica Pharmaceuticals plc (OSMT) stock moved down -2.13 percent to $4.14 ‎in ‎the pre-market trading after declaring that the U.S. Food and Drug Administration (FDA) has ‎declined ‎to approve one of its products. ‎

    ‎Cinedigm Corp. (CIDM) is down more than -0.69% at $0.62 in pre-‎market ‎hours ‎Thursday December 31, 2020. The stock had dropped over -9.51% to $0.62 in the last ‎trading ‎session.‎

    ‎Novan Inc. (NOVN), a Biotechnology company, dropped about -7.71% at $0.969 ‎in ‎pre-market trading Thursday.‎

    Before the trading started on December 31, 2020, Canaan Inc. (CAN) is ‎up ‎‎25.57% ‎to ‎reach $5.5. It has been trading in a 52-week range of $1.76 to $8.69.‎

    ‎500.com Limited (WBAI) gained over 5.12% at $8.0 in pre-market trading ‎Thursday ‎December 31, 2020. The company recently declared that Mr. Zhaofu Tian has resigned as ‎Chief ‎Technology Officer of the Company due to personal reasons.‎

  • Market Movers: What changed for these 21 stocks while you were sleeping

    Market Movers: What changed for these 21 stocks while you were sleeping

    ‎Greenpro Capital Corp. (GRNQ), a Conglomerates company, dropped about -‎‎5.88% ‎at $1.76 in pre-market trading Tuesday after announcing Bitcoin fund.‎

    ‎ATIF Holdings Limited (ATIF) stock plunged -8.51% to $0.9698 in the pre-‎market ‎trading.‎

    ‎Bionano Genomics Inc. (BNGO) stock soared 8.57% to $0.96 in the pre-‎market ‎trading after declaring that Praxis Genomics, LLC received accreditation from the College of ‎American ‎Pathologists (CAP). The most recent rating by Ladenburg Thalmann, on September 24, 2020, ‎is a Buy. ‎

    ‎Zomedica Corp. (AMEX: ZOM) shares are trading up 4.5% at $0.2625 at the ‎time ‎of ‎writing. Company’s 52-week ranged between $0.06 to $0.50.‎

    ‎Nano Dimension Ltd. (NASDAQ: NNDM) shares are trading up 5.52% at $8.6 at ‎the ‎time of writing after pricing $250 million registered direct offering. ‎Company’s 52-week ‎ranged ‎between $0.51 to $10.49. Analysts have a consensus price target of $8. ‎

    ‎Jaguar Health Inc. (JAGX) stock moved down -2.88 percent to $0.7325 in the pre-‎‎market trading.‎

    ‎Ideanomics Inc. (IDEX), a Software – Application company, rose about 4.27% at ‎‎$2.44 ‎in pre-market trading Tuesday following the declaration the signing of an agreement of its ‎Mobile ‎Energy Global (“MEG”) and contracting entity Qingdao Chengyang Medici with Meihao ‎Chuxing, a joint ‎venture between BYD and Didi, to purchase an initial 2,000 units of model BYD D1. ‎

    ‎Alibaba Group Holding Limited (BABA) is up more than 3.64% at $230.45 in pre-‎‎‎market hours Tuesday December 29, 2020. The stock had jumped over 0.16% to $222.36 in ‎the ‎last ‎trading session.‎

    Before the trading started on December 29, 2020, FuelCell Energy Inc. (FCEL) is ‎up ‎‎2.3% to reach $11.81. It has been trading in a 52-week range of $0.84 to $13.91.‎

    ‎AeroCentury Corp. (ACY) lost over -25.7% at $10.29 in pre-market trading ‎Tuesday ‎December 29, 2020 following the update of listing standards compliance.‎

    ‎Color Star Technology Co. Ltd. (CSCW) is down more than -9.21% at $0.69 in pre-‎‎‎market hours Tuesday December 29, 2020. The stock had jumped over 7.04% to $0.76 in ‎the ‎last ‎trading session.‎

    Before the trading started on December 29, 2020, Guardion Health Sciences ‎Inc. ‎‎(GHSI) is up 14.83% to reach $0.36. The firm recently reported the appointment of ‎Bret ‎Scholtes, as its President and Chief Executive Officer, and as a member of the Board of Directors. ‎He is ‎a veteran of the nutritional products industry for nearly a decade. It has been trading in a 52-‎week ‎range of $0.17 to $0.74.‎

    ‎Nokia Corporation (NOK) stock soared 2.31% to $3.99 in the pre-market ‎trading ‎after reporting that it has been selected by Thailand’s dtac as its first 5G partner.‎ The most ‎recent ‎rating by Exane BNP Paribas, on October 30, 2020, is a Neutral. ‎

    Before the trading started on December 29, 2020, Acasti Pharma Inc. (ACST) is ‎up ‎‎7.32% to reach $0.3343. It has been trading in a 52-week range of $0.17 to $2.75.‎

    ‎RMG Acquisition Corp. (RMG) grew over 2.1% at $32.61 in pre-market trading ‎today ‎following the stockholder approval of business combination with Romeo Systems, Inc. with ‎no ‎redemptions.‎

    ‎Aprea Therapeutics Inc. (APRE), a Biotechnology company, rose about 4.73% ‎at ‎‎$5.76 in pre-market trading Tuesday after declaring results of primary endpoint from Phase 3 trial ‎of ‎Eprenetapopt in TP53 Mutant Myelodysplastic Syndromes (MDS).‎

    ‎MicroVision Inc. (NASDAQ: MVIS) shares are trading up 6.41% at $7.14 at ‎the ‎time ‎of writing. Company’s 52-week ranged between $0.15 to $9.74. Analysts have a consensus ‎price ‎target ‎of $4.50.‎

    ‎China Recycling Energy Corporation (CREG) is down more than -2.23% at $5.7 in pre-‎‎market hours Tuesday December 29, 2020 after revealing that it has entered into agreement to ‎acquire ‎Xi’an Taiying Energy Saving Technology ‎Co., Ltd..‎. The stock had jumped over 31.31% to $5.83 in ‎the last ‎trading session. ‎

    ‎BIOLASE Inc. (BIOL) stock moved up 25.44 percent to $0.6021 in the pre-‎market ‎trading.‎

    ‎Borr Drilling Limited (BORR), a Oil & Gas Drilling company, rose about 4.66% ‎at ‎‎$0.854 in pre-market trading Tuesday after reporting the appointment of Mr. Magnus Vaaler as its ‎new ‎Chief Financial Officer. He will replace Mr. Christoph Bausch.‎

    ‎Onconova Therapeutics Inc. (NASDAQ: ONTX) shares are trading up 3.68% ‎at ‎‎$0.465 ‎at the time of writing. Company’s 52-week ranged between $0.19 to $1.56. Analysts have ‎a ‎consensus ‎price target of $7.50.‎

  • Pre-Market Cues: 24 Stocks Roaring for Change On December 28th

    Pre-Market Cues: 24 Stocks Roaring for Change On December 28th

    ‎Avinger Inc. (AVGR) stock plunged -7.38% to $0.4445 in the pre-market trading. The ‎most recent rating by Ladenburg Thalmann, on March 09, 2018, is a Buy. The company lately ‎announced annual meeting results.‎

    ‎Jaguar Health Inc. (JAGX) is up more than 16.5% at $0.833 in pre-market ‎hours ‎Monday December 28, 2020 after signing second agreement for $6 million non-dilutive ‎financing ‎transaction involving the sale of royalty rights. The stock had dropped over -33.18% to $0.71 ‎in the last ‎trading session.‎

    ‎Ocugen Inc. (NASDAQ: OCGN) shares are trading up 52.84% at $2.69 at the time of ‎writing. Company’s 52-week ranged between $0.17 to $3.05.‎

    ‎Senseonics Holdings Inc. (SENS) tumbled over -13.63% at $0.786 in pre-market ‎trading today after declaring financial and operational business updates.‎

    ‎Naked Brand Group Limited (NAKD), a Apparel Manufacturing company, rose about ‎‎2.63% at $0.2145 in pre-market trading Monday after reporting that it has been granted an additional ‎‎180-day period, or until May 24, 2021.‎

    ‎Zomedica Corp. (ZOM) gained over 13.05% at $0.259 in pre-market trading Monday ‎December 28, 2020.‎

    Before the trading started on December 28, 2020, Sundial Growers Inc. (SNDL) is up ‎‎9.23% to reach $0.517. The company today declared concentrates license agreement with Simply ‎Solventless. It has been trading in a 52-week range of $0.14 to $3.88.‎

    ‎Acasti Pharma Inc. (ACST) stock soared 14.17% to $0.377 in the pre-market trading. ‎The most recent rating by Oppenheimer, on September 01, 2020, is a Perform.‎

    ‎Camber Energy Inc. (AMEX: CEI) shares are trading down -7.62% at $0.97 at the time ‎of writing. Company’s 52-week ranged between $0.46 to $4.10.‎

    ‎NIO Limited (NIO), a Auto Manufacturers company, rose about 1.92% at $46.65 in ‎pre-market trading Monday.‎

    ‎FuelCell Energy Inc. (FCEL) stock moved up 10.0 percent to $13.53 in the pre-market ‎trading.‎

    ‎Tonix Pharmaceuticals Holding Corp. (TNXP) gained over 7.86% at $0.7173 in pre-‎market trading Monday December 28, 2020. The firm recently revealed that it has completed the ‎purchase of an approximately 44-acre site in Hamilton, Montana, for the construction of a vaccine ‎development and commercial scale manufacturing facility. ‎

    ‎Guardion Health Sciences Inc. (GHSI) is down more than -9.47% at $0.3097 in pre-‎market hours Monday December 28, 2020. The stock had dropped over -7.89% to $0.34 in the last ‎trading session.‎

    Before the trading started on December 28, 2020, Color Star Technology Co. Ltd. ‎‎(CSCW) is up 30.76% to reach $0.9284. It has been trading in a 52-week range of $0.31 to ‎‎$2.06.‎

    ‎Ampio Pharmaceuticals Inc. (AMPE) stock soared 8.49% to $2.3 in the pre-market ‎trading. The most recent rating by ROTH Capital, on December 19, 2019, is a Buy.‎

    ‎Blink Charging Co. (BLNK), a Specialty Retail company, rose about 4.24% at $51.6 in ‎pre-market trading Monday.‎

    ‎Nikola Corporation (NKLA) stock moved up 2.18 percent to $14.05 in the pre-market ‎trading.‎

    ‎Onconova Therapeutics Inc. (ONTX) gained over 3.39% at $0.4905 in pre-market ‎trading Monday December 28, 2020.‎

    Before the trading started on December 28, 2020, MicroVision Inc. (MVIS) is up ‎‎4.43% to reach $6.84. It has been trading in a 52-week range of $0.15 to $9.74.‎

    ‎Nano Dimension Ltd. (NNDM) stock plunged -13.51% to $7.62 in the pre-market ‎trading after pricing $250 million registered direct offering. The most recent rating by Maxim Group, on ‎October 21, 2016, is a Buy.‎

    ‎Plug Power Inc. (NASDAQ: PLUG) shares are trading up 5.37% at $37.49 at the time ‎of writing. Company’s 52-week ranged between $2.53 to $37.11. Analysts have a consensus price ‎target of $24.‎

    ‎Marathon Patent Group Inc. (MARA) grew over 31.23% at $14.33 in pre-market ‎trading today.‎

    ‎Riot Blockchain Inc. (RIOT), a Software – Application company, rose about 18.22% at ‎‎$15.51 in pre-market trading Monday.‎

    ‎Marathon Oil Corporation (MRO) stock moved up 3.32 percent to $6.85 in the pre-‎market trading.‎